Search

Search Constraints

You searched for: Author/Creator Eaton, Keith D.

Search Results

1. A Phase II study of nab-Paclitaxel (nab-P) in patients with advanced non-small cell lung cancer with EGFR mutations after frontline tyrosine kinase inhibitor therapy. (2021)

2. Timing of postoperative radiation therapy and survival in resected salivary gland cancers: Long-term results from a single institution. (December 2021)

6. Adult Low-Hypodiploid Acute B-Lymphoblastic Leukemia With IKZF3 Deletion and TP53 Mutation: Comparison With Pediatric Patients. Issue 2 (1st August 2015)

7. Socioeconomic factors and outcomes among patients with recurrent/metastatic head and neck cancer receiving immunotherapy. Issue 28 (1st October 2022)

8. Meaningful measures for advanced cancer: Building a measure set to promote goal-concordant care. Issue 28 (1st October 2022)

9. Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients. (29th March 2022)